|
Aug 8
|
Analysts Have Been Trimming Their Curis, Inc. (NASDAQ:CRIS) Price Target After Its Latest Report
|
|
Aug 6
|
Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
|
|
Aug 5
|
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 5
|
Curis: Q2 Earnings Snapshot
|
|
Aug 5
|
Curis Provides Second Quarter 2025 Business Update
|
|
Jul 29
|
Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025
|
|
Nov 14
|
Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 14
|
Curis: Q3 Earnings Snapshot
|
|
Nov 14
|
Curis Provides Third Quarter 2024 Business Update
|
|
Oct 9
|
Curis Inc (CRIS) Q2 2024 Earnings Call Highlights: Promising Clinical Progress Amid Financial ...
|
|
Jul 25
|
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
|
|
May 14
|
Curis Announces Additional Data from TakeAim Leukemia Study
|
|
May 10
|
Curis to Present Updated Data from the TakeAim Leukemia Study
|
|
May 8
|
Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Curis Provides First Quarter 2024 Business Update
|
|
Apr 5
|
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
|
|
Apr 5
|
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
|
|
Apr 4
|
Curis to Present at Upcoming Healthcare Conferences in April
|
|
Feb 9
|
Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript
|
|
Feb 8
|
Curis Provides Fourth Quarter 2023 Business Update
|